menu
    • menu

    Company profile for MiroBio

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission at MiroBio is to develop novel, best-in-class therapeutics that bring significant benefits to patients suffering from a range of auto-immune diseases. MiroBio's medicines will activate natural mechanisms to regain control of over-active immune responses triggering these diseases. A new approach to autoimmunity: Checkpoint agonist antibodies, MiroBio’s unique approach to restore balance to the immune system is rem...
    Our mission at MiroBio is to develop novel, best-in-class therapeutics that bring significant benefits to patients suffering from a range of auto-immune diseases. MiroBio's medicines will activate natural mechanisms to regain control of over-active immune responses triggering these diseases. A new approach to autoimmunity: Checkpoint agonist antibodies, MiroBio’s unique approach to restore balance to the immune system is reminiscent of the kintsugi technique which unites pottery pieces to create new function and beauty.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MiroBiounitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    BioEscalator Roosevelt Drive Oxford
    Telephone
    Telephone
    01865 618817
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mirobio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mirobio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gilead Sciences Completes Acquisition of MiroBio
    Gilead Sciences Completes Acquisition of MiroBio

    20 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220919005772/en

    BUSINESSWIRE
    20 Sep 2022
    Share Share
    Gilead Sciences to acquire OSE portfolio company for approximately $405m
    Gilead Sciences to acquire OSE portfolio company for approximately $405m

    16 Aug 2022

    // PHARMACEUTICAL MANUFACTURER

    https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/pharma-finance-and-investment-news/ose-portfolio-company-to-be-acquired-by-gilead-sciences-for-/

    PHARMACEUTICAL MANUFACTURER
    16 Aug 2022
    Share Share
    Gilead buys MiroBio as it takes next-gen checkpoint therapy to the clinic
    Gilead buys MiroBio as it takes next-gen checkpoint therapy to the clinic

    05 Aug 2022

    // Lei Lei Wu ENDPTS

    https://endpts.com/looking-to-bolster-immune-checkpoint-rd-gilead-buys-mirobio-as-it-takes-next-gen-checkpoint-therapy-to-the-clinic/

    Lei Lei Wu ENDPTS
    05 Aug 2022
    Share Share
    MiroBio Raises $97M Series B Financing to Develop Checkpoint Agonists
    MiroBio Raises $97M Series B Financing to Develop Checkpoint Agonists

    29 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/29/2471132/0/en/MiroBio-Raises-97-Million-Series-B-Financing-to-Develop-Checkpoint-Agonists-for-Treatment-of-Autoimmune-Diseases.html

    GLOBENEWSWIRE
    29 Jun 2022
    Share Share
    Oxford spinout nabs almost $100M in new cash
    Oxford spinout nabs almost $100M in new cash

    28 Jun 2022

    // Kyle LaHucik ENDPTS

    https://endpts.com/an-oxford-spinout-nabs-a-series-b-to-begin-autoimmune-trial-in-the-uk-and-hunt-for-a-ceo/

    Kyle LaHucik ENDPTS
    28 Jun 2022
    Share Share
    MiroBio Continues Expansion of Executive Leadership Team
    MiroBio Continues Expansion of Executive Leadership Team

    08 Mar 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/03/08/2398672/0/en/MiroBio-Continues-Expansion-of-Executive-Leadership-Team-with-Key-Appointments-to-Advance-Development-of-Checkpoint-Agonist-Antibodies-for-Autoimmune-Disease.html

    GLOBENEWSWIRE
    08 Mar 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search